Cyanidin-3-O-β-glucoside with the aid of its metabolite protocatechuic acid, reduces monocyte infiltration in apolipoprotein E-deficient mice - PubMed (original) (raw)
. 2011 Oct 1;82(7):713-9.
doi: 10.1016/j.bcp.2011.04.007. Epub 2011 May 5.
Affiliations
- PMID: 21569764
- DOI: 10.1016/j.bcp.2011.04.007
Cyanidin-3-O-β-glucoside with the aid of its metabolite protocatechuic acid, reduces monocyte infiltration in apolipoprotein E-deficient mice
Dongliang Wang et al. Biochem Pharmacol. 2011.
Abstract
Polyphenols, including anthocyanins, from various plant foods are effective in reducing the severity of atherosclerosis in animal and human studies. Due to the poor understanding of the bioavailability of anthocyanins, the potential antiatherogenic mechanisms underlying the action remain largely unknown. Herein, we found that oral gavage of cyanidin-3-O-β-glucoside (Cy-3-G) could be transformed into protocatechuic acid (PCA), and the plasma maximal levels of Cy-3-G were 3.7-fold lower than that of PCA in the apolipoprotein E (ApoE)-deficient mice. Subsequently, we observed that PCA treatment has a higher capacity than Cy-3-G treatment in decreasing CC chemokine receptor 2 (CCR2) expression in the mouse peripheral blood monocytes (PBMs), along with reducing the mouse PBMs chemokine toward CC ligand-2 (CCL2) in a Boyden chamber. Interesting, in the ApoE-deficient mouse model, orally gavaged with Cy-3-G has a higher ability than gavaged with PCA to reduce CCR2 expression in PBMs. PBMs deprived from the Cy-3-G-treated ApoE-deficient mice have a lower ability than those from PCA-treated animals to migrate toward CCL2. Furthermore, as compared with the PCA group, Cy-3-G treatment more efficiently reduced thioglycollate-induced macrophage infiltration into the abdominal cavity. Thus, we suggest that Cy-3-G may reduce the monocyte infiltration in mice via down-regulation of CCR2 expression in monocytes, at least in part, with the aid of its metabolite PCA. These above data imply that the anti-monocyte/macrophage infiltration property of Cy-3-G and its metabolite PCA may be an important antiatherogenic mechanism for anthocyanins.
Copyright © 2011. Published by Elsevier Inc.
Similar articles
- Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b.
Wang D, Xia M, Yan X, Li D, Wang L, Xu Y, Jin T, Ling W. Wang D, et al. Circ Res. 2012 Sep 28;111(8):967-81. doi: 10.1161/CIRCRESAHA.112.266502. Epub 2012 Jul 19. Circ Res. 2012. PMID: 22821931 - Protocatechuic acid, a metabolite of anthocyanins, inhibits monocyte adhesion and reduces atherosclerosis in apolipoprotein E-deficient mice.
Wang D, Wei X, Yan X, Jin T, Ling W. Wang D, et al. J Agric Food Chem. 2010 Dec 22;58(24):12722-8. doi: 10.1021/jf103427j. Epub 2010 Nov 22. J Agric Food Chem. 2010. PMID: 21090717 - Cyanidin-3-O-β-glucoside upregulates hepatic cholesterol 7α-hydroxylase expression and reduces hypercholesterolemia in mice.
Wang D, Xia M, Gao S, Li D, Zhang Y, Jin T, Ling W. Wang D, et al. Mol Nutr Food Res. 2012 Apr;56(4):610-21. doi: 10.1002/mnfr.201100659. Mol Nutr Food Res. 2012. PMID: 22495986 - Some anthocyanins could be efficiently absorbed across the gastrointestinal mucosa: extensive presystemic metabolism reduces apparent bioavailability.
Fang J. Fang J. J Agric Food Chem. 2014 May 7;62(18):3904-11. doi: 10.1021/jf405356b. Epub 2014 Mar 31. J Agric Food Chem. 2014. PMID: 24650097 Review. - New progress in the pharmacology of protocatechuic acid: A compound ingested in daily foods and herbs frequently and heavily.
Song J, He Y, Luo C, Feng B, Ran F, Xu H, Ci Z, Xu R, Han L, Zhang D. Song J, et al. Pharmacol Res. 2020 Nov;161:105109. doi: 10.1016/j.phrs.2020.105109. Epub 2020 Jul 30. Pharmacol Res. 2020. PMID: 32738494 Review.
Cited by
- Dietary Anthocyanins and Insulin Resistance: When Food Becomes a Medicine.
Belwal T, Nabavi SF, Nabavi SM, Habtemariam S. Belwal T, et al. Nutrients. 2017 Oct 12;9(10):1111. doi: 10.3390/nu9101111. Nutrients. 2017. PMID: 29023424 Free PMC article. Review. - MicroRNA control of high-density lipoprotein metabolism and function.
Rayner KJ, Moore KJ. Rayner KJ, et al. Circ Res. 2014 Jan 3;114(1):183-92. doi: 10.1161/CIRCRESAHA.114.300645. Circ Res. 2014. PMID: 24385511 Free PMC article. Review. - Role of gut microbiota in cardiovascular diseases.
Novakovic M, Rout A, Kingsley T, Kirchoff R, Singh A, Verma V, Kant R, Chaudhary R. Novakovic M, et al. World J Cardiol. 2020 Apr 26;12(4):110-122. doi: 10.4330/wjc.v12.i4.110. World J Cardiol. 2020. PMID: 32431782 Free PMC article. Review. - High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women.
Cassidy A, Mukamal KJ, Liu L, Franz M, Eliassen AH, Rimm EB. Cassidy A, et al. Circulation. 2013 Jan 15;127(2):188-96. doi: 10.1161/CIRCULATIONAHA.112.122408. Circulation. 2013. PMID: 23319811 Free PMC article. - From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport.
Dávalos A, Fernández-Hernando C. Dávalos A, et al. Pharmacol Res. 2013 Sep;75:60-72. doi: 10.1016/j.phrs.2013.02.005. Epub 2013 Feb 19. Pharmacol Res. 2013. PMID: 23435093 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous